高危子宫内膜癌术后辅助同步放化疗与单纯放疗的临床对比
Comparative Study of Concurrent Chemoradiotherapy with Simplex Radiotherapy after Radical Surgery for High-risk Endometrial Cancer
-
摘要: [摘要]目的 对比研究顺铂联合五氟尿嘧啶(PF方案)同步放化疗与单纯放疗辅助治疗术后高危子宫内膜癌的毒性反应和复发,发现盆腔或远处转移病灶.方法 选择2011年10月至2013年6月云南省肿瘤医院初治、接受规范分期手术,有高危因素的子宫内膜癌患者43例为研究对象,22例行单纯放射治疗,21例行术后辅助DDP+5-FU同步放化疗治疗,对比2组的毒性反应和复发率.结果 同步放化疗组与单纯放疗组3极胃肠道反应率分别为61.90%和31.82%(P<0.05 ),差异有统计学意义;2组2级以上骨髓抑制率分别为66.67%和18.18 %(P<0.01 ),差异有统计学意义;2组2级以上周围神经毒性反应率分别为33.33%和13.64%(P>0.05 ) .同步放化疗组与单纯放疗组总体复发率分别为4.76%和27.27%(P<0.05 ),差异有统计学意义.结论 同步放化疗3级胃肠道反应率增加,2级以上骨髓抑制率显著增加,周围神经毒性反应率不增加,毒性反应可以耐受,减少2 a总体复发率.
-
关键词:
- [关键词]子宫内膜癌 /
- 同步放化疗 /
- 放射治疗
Abstract: [Abstract]Objective To compare the toxicities and recurrence rate with concomitant chemoradiotherapy(CRT) and radiotherapy(RT) alone after radical surgery for high-risk endometrial cancer. Methods A total of 43 patients with high-risk endometrial cancer who received standard surgery treatment from Yunnan Cancer Hospital between Oct. 2011 to Jun. 2014 were selected in this study. CRT was given to 21 patients and RT was given to 22 patients. The toxic reactions and the recurrence rate were compared between two groups. Results In Concurrent chemotherapy and radiotherapy alone group, the incidence of Grade 3 gastrointestinal reaction was 61.90% and 31.82% respectively,the difference was statistically significant(P <0.05); the incidence of Grade 2 marrow suppression was 66.67% and 18.18% respectively,the difference was significant(P <0.01);the incidence of Grade 2 neurotoxicity was 33.33% and 13.64%,respectively(P > 0.05);the overall recurrence rate was 4.76% and 27.27%, respectively (P <0.05). Conclusion Compared with the simple radiotherapy,after the concurrent chemoradiotherapy, the incidence of Grade 3 gastrointestinal reaction may increase,the incidence of Grade 2 Bone marrow suppression may also increase significantly,while the incidence of peripheral neurotoxicity may not increase,the toxicity is acceptable, and the 2-year recurrence rate may decrease. 期刊类型引用(8)
1. 胡焓,罗欢. 超声引导下0.5%罗哌卡因股神经阻滞镇痛在髌骨骨折切开复位内固定术中的应用效果. 现代诊断与治疗. 2024(03): 374-376 . 百度学术
2. 傅从良,冯伊文. 超声引导下股神经阻滞在髌骨骨折患者术后镇痛中的应用效果. 世界复合医学(中英文). 2024(08): 137-140 . 百度学术
3. 祁恩耀,许娟,龚睿,张云辉,王鹏. 右美托咪定复合罗哌卡因收肌管阻滞在胫骨折患者术前超前镇痛中的应用. 系统医学. 2024(19): 64-67 . 百度学术
4. 叶映芬,李昆伦,陈伟元,赖尚导. 右美托咪定在骨科手术麻醉与镇痛中的应用进展. 药学前沿. 2024(12): 711-718 . 百度学术
5. 李娟,杨璐,汤娜娜,曹福羊. 近端联合远端收肌管阻滞在全膝关节置换术患者术后镇痛和早期功能康复中的应用. 安徽医学. 2023(01): 68-73 . 百度学术
6. 杨云丽,李娜,邱昌明,普俊杰,聂维,李治贵. 超声引导下前路腰方肌阻滞对髋关节手术患儿术后镇痛效果. 昆明医科大学学报. 2023(04): 88-92 . 本站查看
7. 董红坤,王朝君,孟醒. 联合激光疗法对髌骨骨折术后患者炎症吸收水平、膝关节功能康复的影响. 江苏卫生保健. 2023(03): 175-177 . 百度学术
8. 于天雷,刘颖,张兰. 右美托咪定复合0.2%罗哌卡因股神经阻滞对髌骨骨折的镇痛效果及神经递质的影响. 创伤外科杂志. 2023(09): 709-714 . 百度学术
其他类型引用(3)
-

计量
- 文章访问数: 3187
- HTML全文浏览量: 1108
- PDF下载量: 136
- 被引次数: 11